Tag: Regenerative Macrophage Therapy
-
Resolution Therapeutics Announces Regenerative Macrophage Therapy Data for Cirrhosis at AASLD 2025
Overview: New Data Spotlight Regenerative Macrophage Therapy Resolution Therapeutics has announced key updates from its ongoing research into Regenerative Macrophage Therapy (RMT) for cirrhosis, with fresh data presented at AASLD 2025. The company highlighted early signals from the MATCH Phase II study showing that patients receiving non-engineered macrophages exhibit early improvements in liver function. In…
-
Resolution Therapeutics Unveils Early MATCH Phase II Data; Regenerative Macrophage Therapy Shows Promise for Cirrhosis at AASLD 2025
Groundbreaking DATA at AASLD 2025 Resolution Therapeutics presented new clinical and preclinical data at AASLD 2025 highlighting the potential of Regenerative Macrophage Therapy for cirrhosis. The company reported early improvements in liver function in the MATCH Phase II study using non-engineered macrophages, with associations to favorable long-term clinical outcomes. These findings position Resolution’s macrophage-based approach…